Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Kenneth Gillman

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Clinical Psychopharmacology|December 31, 2010
Advances pertaining to the pharmacology and interactions of irreversible nonselective monoamine oxidase inhibitorsPeter Kenneth Gillman
Journal of Neural Transmission (Vienna, Austria : 1996)|September 27, 2018
A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine mythsPeter Kenneth Gillman
Psychopharmacology Bulletin|June 20, 2022
The Prescriber's Guide to the MAOI Diet-Thinking Through Tyramine TroublesVincent Van den Eynde, Peter Kenneth Gillman, Barry B Blackwell
Journal of Psychoactive Drugs|June 21, 2024
Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and TranylcypromineBrian S Barnett, Curtis J Koons, Vincent Van den Eynde, et al.
CNS Drugs|January 17, 2026
Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment DataGaëlle Rached, Anna Campana, Dimitri Fiani, et al.
Psychopharmacology Bulletin|August 21, 2023
On the Origins of MAOI Misconceptions: Reaffirming their Role in Melancholic DepressionVincent Van den Eynde, Gordon Parker, Henricus G Ruhé, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Clinical Psychopharmacology|December 31, 2010
Advances pertaining to the pharmacology and interactions of irreversible nonselective monoamine oxidase inhibitorsPeter Kenneth Gillman
Journal of Neural Transmission (Vienna, Austria : 1996)|September 27, 2018
A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine mythsPeter Kenneth Gillman
Psychopharmacology Bulletin|June 20, 2022
The Prescriber's Guide to the MAOI Diet-Thinking Through Tyramine TroublesVincent Van den Eynde, Peter Kenneth Gillman, Barry B Blackwell
Journal of Psychoactive Drugs|June 21, 2024
Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and TranylcypromineBrian S Barnett, Curtis J Koons, Vincent Van den Eynde, et al.
CNS Drugs|January 17, 2026
Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment DataGaëlle Rached, Anna Campana, Dimitri Fiani, et al.
Psychopharmacology Bulletin|August 21, 2023
On the Origins of MAOI Misconceptions: Reaffirming their Role in Melancholic DepressionVincent Van den Eynde, Gordon Parker, Henricus G Ruhé, et al.
Pageof 1